New England Journal of Medicine

Vol. 394, Issue 7 Issue 7 2026
20
Articles

Articles in this Issue

Mucormycosis

Dimitrios P. Kontoyiannis, Thomas J. Walsh Feb 12, 2026 pp. 684-698 10.1056/nejmra2412565

Drug Labels as Evidence of Patent Infringement — A Troubling Legal Trend

Paul R. Gugliuzza, Jacob S. Sherkow Feb 12, 2026 pp. 630-632 10.1056/nejmp2518212

Reviewers for the <i>Journal</i> , July–December 2025

Eric J. Rubin Feb 12, 2026 pp. 711-711 10.1056/nejme2600286

Case 5-2026: An 18-Year-Old Woman with Headache and Hypertension

Paul K. Fadakar, Ali Pourvaziri, Adam S. Feldman et al. Feb 12, 2026 pp. 700-709 10.1056/nejmcpc2412521

Belzutifan for Advanced Pheochromocytoma or Paraganglioma

Feb 12, 2026 pp. 726-728 10.1056/nejmc2518226

Hepatic Angiosarcoma

Nicola Mumoli, Giovanni Serio Feb 12, 2026 10.1056/nejmicm2514897

Pulmonary Mucormycosis

Jonas Lötscher, Justus Baarts Feb 12, 2026 pp. 699-699 10.1056/nejmicm2511883

Adenoviral Inciting Antigen and Somatic Hypermutation in VITT

Jing Jing Wang, Linda Schönborn, Theodore E. Warkentin et al. Feb 12, 2026 pp. 669-683 10.1056/nejmoa2514824

Overdose, Homicide, and Suicide as Causes of Maternal Death in the United States

Hooman A. Azad, Dana Goin, Lisa M. Nathan et al. Feb 12, 2026 pp. 722-723 10.1056/nejmc2512078

Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial

Vlado Perkovic, Hernán Trimarchi, Vladimir Tesař et al. Feb 12, 2026 pp. 635-646 10.1056/nejmoa2512133

Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer

Feb 12, 2026 pp. 728-728 10.1056/nejmx240009

The Next Chapter in Health Care Interoperability

John D. Halamka, Micky Tripathi Feb 12, 2026 pp. 628-630 10.1056/nejmp2511798

Improving Regulations for Human Subjects Research

Linda Coleman, Katie Wullert Feb 12, 2026 pp. 716-721 10.1056/nejmsb2516485

Paget’s Disease of the Breast

Feb 12, 2026 pp. 728-728 10.1056/nejmx260001

The Rural Health Transformation Program — An Avenue for Promoting Administrative Policies

Heather Howard, Carmel Shachar Feb 12, 2026 pp. 625-627 10.1056/nejmp2515454

A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy

Richard Lafayette, Sean J. Barbour, Robert M. Brenner et al. Feb 12, 2026 pp. 647-657 10.1056/nejmoa2510198

A Pediatrician’s Dilemma — Pushing Back against CDC Guidance in the Exam Room

Dorothy R. Novick Feb 12, 2026 pp. 632-633 10.1056/nejmp2517911

Potassium Levels and Risk of Ventricular Arrhythmias

Feb 12, 2026 pp. 723-726 10.1056/nejmc2518640

Thromboprophylaxis for Atrial Fibrillation in Patients with Drug-Eluting Stents

Gregory Y.H. Lip, Lukasz Kuzma Feb 12, 2026 pp. 713-715 10.1056/nejme2517711

Targeting the Pathogenesis of IgA Nephropathy — A New Treatment Approach?

Marcello Tonelli Feb 12, 2026 pp. 712-713 10.1056/nejme2518418

All Issues

Journal Info

Publisher Massachusetts Medical Society
ISSN 0028-4793
E-ISSN 0096-6762
Subject Social Sciences
Language English
View Full Journal Page